Stemline is a commercial-stage biopharmaceutical company committed to applying our scientific leadership and commercial expertise to transform the lives of patients with cancer.
ELZONRIS a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with BPDCN. In Europe, a marketing authorization application (MAA) is under review by the European Medicines Agency (EMA).
Inspired by the goal to improve outcomes for patients with unmet medical needs,
Stemline is driven to discover and develop innovative therapeutics for the treatment of cancer. Currently our clinical-stage product candidates in include ELZONRIS, SL-701 and SL801.
Location: United States, New York
Member count: 51-200
Founded date: 2003
Investors 1
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
Mentions in press and media 10
| Date | Title | Description | Category | Author | Source |
| 04.05.2020 | Italy’s Me... | Shares of Stemline were up 153... | - | - | medcitynew... |
| 20.02.2019 | Xencor leu... | Under the partial clinical hol... | - | - | medcitynew... |
| 03.02.2017 | Stemline ... | Adam Feuerstein, Twitter • ... | - | Shehla Sha... | endpts.com... |
| 23.08.2016 | Little St... | Back at the big ASCO meeting... | - | John Carro... | endpts.com... |
| 03.04.2012 | Cancer the... | Last year its brain cancer vac... | - | - | medcitynew... |
| 09.04.2008 | Life-scien... | TODAY’S HEADLINES: Stemline Th... | - | - | venturebea... |
| 19.01.2005 | Cambridge ... | Cambridge scientists develop t... | - | - | cambridgen... |
| - | Cancer the... | A biopharmaceutical company de... | - | - | medcitynew... |
| - | Xencor leu... | Two deaths in a clinical trial... | - | - | medcitynew... |
| - | Italy’s Me... | An Italian pharmaceutical and ... | - | - | medcitynew... |